Bromide

Bromide

SCHEMBL5552280

Br.N=C(S)NCc1c(F)cccc1F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.38
ROCK1 Q13464 2/20 0.38
MAPK14 Q16539 3/20 0.37
BACE1 P56817 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GAA P10253 1/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
P2RX7 Q99572 2/20 0.33
DNMT3B Q9UBC3 1/20 0.33
CNR1 P21554 1/20 0.33
ATM Q13315 1/20 0.33
HTT P42858 1/20 0.33
KLKB1 P03952 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27709504 0.98 ROCK2 (0.39) ROCK2ROCK1MAPK14BACE1MEN1
Hydrochloric Acid SCHEMBL3658158 0.96 ROCK2 (0.38) ROCK2ROCK1MAPK14BACE1MEN1
SCHEMBL3658658 0.76 CYP1A2 (0.41) ROCK2ROCK1BACE1KMT2AGAA
SCHEMBL2814423 0.74 MAPT (0.36) MEN1KMT2ANPC1P2RX7HTT
Hydrochloric Acid SCHEMBL17707535 0.74 HTT (0.42) ROCK2ROCK1BACE1GAANPC1
SCHEMBL17198841 0.73 BACE1 (0.41) ROCK2ROCK1MAPK14BACE1MEN1
Bromide SCHEMBL2811699 0.72 ALDH1A1 (0.50) MEN1KMT2APOLB
SCHEMBL3557822 0.72 CYP1A2 (0.48) ROCK2ROCK1MAPK14MEN1KMT2A
Bromide SCHEMBL4918498 0.72 MEN1 (0.37) MEN1KMT2AGAANPC1
Bromide SCHEMBL2810282 0.71 NPC1 (0.39) MEN1KMT2AGAANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015805-A1 Process for preparing 3-arylmethylthio- and 3-heteroarylmethylthio-4,5-dihydroisoxazoline derivatives BAYER CROPSCIENCE GMBH (DE) 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015805-A1 Process for preparing 3-arylmethylthio- and 3-heteroarylmethylthio-4,5-dihydroisoxazoline derivatives CYP3A7, KMO, CYP4X1 ROCK2 3833/4885ROCK1 3659/4885MAPK14 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.